Back to search
FDAFDA · Food and drugs·Recall number D-0978-2018

Triamterene and Hydrochlorothiazide Tablets, USP 37.5 mg/25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals, Inc. Morgantown, WV 26505, NDC 0378-1352-01

Published July 18, 2018 · Recall initiated: July 9, 2018

Summary

FDA records drug Class III recall D-0978-2018, published July 18, 2018 and initiated July 9, 2018. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 28,436 bottles; Lot: Lot #: 2007979, Exp. 11/30/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Nationwide within the United States
Lot
Lot #: 2007979, Exp. 11/30/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Triamterene and Hydrochlorothiazide Tablets, USP 37.5 mg/25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals, Inc. Morgantown, WV 26505, NDC 0378-1352-01 recalled?

Yes. FDA published recall D-0978-2018 on July 18, 2018. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter